Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Chubb
Healthtrust
Boehringer Ingelheim
Accenture

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 9,765,147

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,765,147
Title:Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer
Abstract: Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with PD-1/PD-L1 inhibitors are provided.
Inventor(s): Wong; Brian (Los Altos, CA), Hambleton; Julie (San Francisco, CA), Sikorski; Robert (Woodside, CA), Masteller; Emma (Redwood City, CA), Hestir; Kevin (Kensington, CA), Bellovin; David (South San Francisco, CA), Lewis; Katherine E. (Lake Forest Park, WA)
Assignee: Five Prime Therapeutics, Inc. (South San Francisco, CA) Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:14/925,534
Patent Claims:see list of patent claims

Details for Patent 9,765,147

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 001 2015-03-04 ➤ Sign Up Five Prime Therapeutics, Inc. (South San Francisco, CA) Bristol-Myers Squibb Company (Princeton, NJ) 2034-10-29 RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 002 2015-03-04 ➤ Sign Up Five Prime Therapeutics, Inc. (South San Francisco, CA) Bristol-Myers Squibb Company (Princeton, NJ) 2034-10-29 RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125554 001 2015-11-23 ➤ Sign Up Five Prime Therapeutics, Inc. (South San Francisco, CA) Bristol-Myers Squibb Company (Princeton, NJ) 2034-10-29 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
McKesson
Merck
Julphar
Fuji
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.